Application of non-bioartificial liver combined with liver transplantation in treating mid-or end-stage chronic serious hepatitis

XIA Jie,XIANG De-dong,YANG Zhan-yu,ZHANG Nan,GUO Peng,ZHOU Ji-jun,WANG Yu-ming

DOI: https://doi.org/10.3760/j.issn:1000-6680.2007.07.009

2007-01-01

Abstract:Objective To evaluate the application of non-bioartificial liver support system (ALSS) combined with liver transplantation(LT) in treating mid-or end-stage chronic severe hepati- tis.Methods ALSS plus liver transplantation were employed in treating 28 patients with mid-or end- stage chronic severe hepatitis.Clinical data from the patients before and after treatment were collect- ed.The survive rate of ALSS plus LT group were compared with that of medication group 99 cases and medication plus ALSS group 30 cases.The data were analyzed with t test and X~2 test.Results After 57 times ALSS treatment,the serum total bilirubin(TBil),prothromin time(PT),bile acid, blood urea nitrogen(BUN),creatnine(Cr) and ammonia of all the 28 patients got improved(P 0.05).The clinical symptoms and signs of the patients were ameliorated at median 3 d(1～153 d). All patients were bridged to liver transplantation successfully after median 20 d(1～153 d).The 3 and 6 months post-operation survival rate of ALSS plus LT group(71.4%,71.4%) were significantly higher than those in medication group(18.2%,11.1%) and medication plus ALSS group(36.7%, 26.6%)(P<0.01).Conclusions Non-bioartificial liver support system can effectively improve the conditions of patients with mid-or end-stage chronic severe hepatitis before operation,and provide supportive effect as a bridge to liver transplantation.Preoperative non-bioartificial liver support sys tem combined with liver transplantation is the most reliable and effective treatment in mid-or end-stage chronic severe hepatitis.